{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:03:38Z","timestamp":1781024618283,"version":"3.54.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.imlet.2025.107108","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T07:58:16Z","timestamp":1762415896000},"page":"107108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Siglec-1+ macrophages in anti-tumor immunity"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5240-4280","authenticated-orcid":false,"given":"Fran\u00e7ois-Xavier","family":"Mauvais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3782-0750","authenticated-orcid":false,"given":"Peter","family":"van Endert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2025.107108_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101764","article-title":"Cross-presentation by the others","volume":"67","author":"Mauvais","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13030330","article-title":"Exploring CD169+ macrophages as key targets for vaccination and therapeutic interventions","volume":"13","author":"Bouma","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.imlet.2025.107108_bib0003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cellimm.2018.05.005","article-title":"Origin and specialization of splenic macrophages","volume":"330","author":"A-Gonzalez","year":"2018","journal-title":"Cell Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/br.2020.1402","article-title":"Functions of CD169 positive macrophages in human diseases (Review)","volume":"14","author":"Liu","year":"2021","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.imlet.2025.107108_bib0005","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cell.2007.10.046","article-title":"Antigen presentation the macrophage way","volume":"131","author":"Martinez-Pomares","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2025.107108_bib0006","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06287","article-title":"Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells","volume":"450","author":"Junt","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2025.107108_bib0007","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.immuni.2012.07.011","article-title":"Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes","volume":"37","author":"Gerner","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107108_bib0008","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.immuni.2014.12.024","article-title":"Strategically localized dendritic cells promote rapid T cell responses to lymph-borne particulate antigens","volume":"42","author":"Gerner","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107108_bib0009","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cellimm.2018.01.010","article-title":"Lymph node macrophages: scavengers, immune sentinels and trophic effectors","volume":"330","author":"Bellomo","year":"2018","journal-title":"Cell Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0010","doi-asserted-by":"crossref","unstructured":"Gray EE, Cyster JG. Lymph node macrophages. J Innate Immun 2012;4:424\u201336. https:\/\/doi.org\/000337007.","DOI":"10.1159\/000337007"},{"key":"10.1016\/j.imlet.2025.107108_bib0011","doi-asserted-by":"crossref","first-page":"49274","DOI":"10.1074\/jbc.M409300200","article-title":"Identification of sialoadhesin as a dominant lymph node counter-receptor for mouse macrophage galactose-type C-type lectin 1","volume":"279","author":"Kumamoto","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.imlet.2025.107108_bib0012","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1182\/blood.V97.1.288","article-title":"Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations","volume":"97","author":"Hartnell","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2025.107108_bib0013","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.4049\/jimmunol.166.6.3637","article-title":"Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1)","volume":"166","author":"van den Berg","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0014","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1073\/pnas.1320924111","article-title":"Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance","volume":"111","author":"Ravishankar","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imlet.2025.107108_bib0015","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.1745","article-title":"Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation","volume":"10","author":"Phan","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0016","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2012.01.013","article-title":"B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity","volume":"36","author":"Moseman","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107108_bib0017","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/nyas.12387","article-title":"The role of lymph node sinus macrophages in host defense","volume":"1319","author":"Kuka","year":"2014","journal-title":"Ann. N Acad. Sci."},{"key":"10.1016\/j.imlet.2025.107108_bib0018","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fimmu.2019.00347","article-title":"Lymph node subcapsular sinus macrophages as the frontline of lymphatic immune defense","volume":"10","author":"Louie","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0019","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ni.2169","article-title":"Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus","volume":"13","author":"Honke","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0020","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.22382","article-title":"Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists","volume":"56","author":"York","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2025.107108_bib0021","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.2337\/db13-1777","article-title":"A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes","volume":"63","author":"Ferreira","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2025.107108_bib0022","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1089\/aid.2015.0003","article-title":"Increased expression of CD169 on blood monocytes and its regulation by virus and CD8 T cells in macaque models of HIV infection and AIDS","volume":"31","author":"Kim","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.imlet.2025.107108_bib0023","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/ajcp\/aqae127","article-title":"Validation of monocyte CD169 expression as a valuable rapid diagnostic marker of SARS-CoV-2 and other acute viral infections","volume":"163","author":"Pratesi","year":"2025","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.imlet.2025.107108_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010479","article-title":"CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses","volume":"18","author":"Jalloh","year":"2022","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.imlet.2025.107108_bib0025","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1038\/s41467-022-34001-5","article-title":"Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2025.107108_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.697840","article-title":"CD169 defines activated CD14+ monocytes with enhanced CD8+ T cell activation capacity","volume":"12","author":"Affandi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004751","article-title":"CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies","volume":"11","author":"Akiyama","year":"2015","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.imlet.2025.107108_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003291","article-title":"Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1\/CD169","volume":"9","author":"Puryear","year":"2013","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.imlet.2025.107108_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038258","article-title":"Subcapsular sinus macrophage fragmentation and CD169+ bleb acquisition by closely associated IL-17-committed innate-like lymphocytes","volume":"7","author":"Gray","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.imlet.2025.107108_bib0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clim.2015.12.001","article-title":"Siglec-1-positive plasmacytoid dendritic cells (pDCs) in human peripheral blood: a semi-mature and myeloid-like subset imbalanced during protective and autoimmune responses","volume":"163","author":"Wilhelm","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0031","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.imlet.2025.107108_bib0032","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni.1853","article-title":"CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes","volume":"11","author":"Barral","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0033","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2004.11.013","article-title":"The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node","volume":"22","author":"Sixt","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107108_bib0034","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.192.10.1425","article-title":"Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex","volume":"192","author":"Gretz","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2025.107108_bib0035","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ni1494","article-title":"Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells","volume":"8","author":"Phan","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0036","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.immuni.2007.06.007","article-title":"B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node","volume":"27","author":"Carrasco","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107108_bib0037","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1073\/pnas.1423356112","article-title":"CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells","volume":"112","author":"Bernhard","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imlet.2025.107108_bib0038","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1073\/pnas.0909541107","article-title":"Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells","volume":"107","author":"Backer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imlet.2025.107108_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020183","article-title":"Activation of CD8+ T cell responses after melanoma antigen targeting to CD169+ antigen presenting cells in mice and humans","volume":"11","author":"van Dinther","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.imlet.2025.107108_bib0040","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.celrep.2018.01.021","article-title":"Functional CD169 on macrophages mediates interaction with dendritic cells for CD8+ T cell cross-priming","volume":"22","author":"van Dinther","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.imlet.2025.107108_bib0041","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.immuni.2010.12.011","article-title":"CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens","volume":"34","author":"Asano","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107108_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116351","article-title":"CD169+ macrophages identify and eliminate tumor cells in colorectal cancer through CD169\/CD43 interaction and FasL-driven apoptosis","volume":"44","author":"Hu","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.imlet.2025.107108_bib0043","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.celrep.2016.07.010","article-title":"Tissue-resident CD169(+) macrophages form a crucial front line against plasmodium infection","volume":"16","author":"Gupta","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.imlet.2025.107108_bib0044","article-title":"Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes","volume":"220","author":"Culemann","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2025.107108_bib0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.it.2011.11.001","article-title":"CD169+ macrophages at the crossroads of antigen presentation","volume":"33","author":"Martinez-Pomares","year":"2012","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0046","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","article-title":"Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets","volume":"35","author":"Cassetta","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.imlet.2025.107108_bib0047","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107108_bib0048","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s43018-023-00691-z","article-title":"Sirp\u03b1 on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47","volume":"5","author":"Huang","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.imlet.2025.107108_bib0049","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41586-024-07529-3","article-title":"Obesity induces PD-1 on macrophages to suppress anti-tumour immunity","volume":"630","author":"Bader","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2025.107108_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216568","article-title":"Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway","volume":"582","author":"Ding","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.imlet.2025.107108_bib0051","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","article-title":"Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer","volume":"55","author":"Nixon","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107108_bib0052","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.immuni.2017.07.014","article-title":"Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression","volume":"47","author":"Zhu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107108_bib0053","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1084\/jem.20151193","article-title":"Tumor macrophages are pivotal constructors of tumor collagenous matrix","volume":"213","author":"Afik","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2025.107108_bib0054","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155022","article-title":"CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity","volume":"7","author":"Modak","year":"2022","journal-title":"JCI. Insight."},{"key":"10.1016\/j.imlet.2025.107108_bib0055","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1172\/JCI97642","article-title":"Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance","volume":"129","author":"Muraoka","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2025.107108_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112732","article-title":"Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma","volume":"42","author":"Patterson","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.imlet.2025.107108_bib0057","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/8873767","article-title":"CD169 Expression in lymph nodes is associated with increased infiltration of CD8+ T cells in tumors: a systematic review and meta-analysis","volume":"2024","author":"Wang","year":"2024","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.imlet.2025.107108_bib0058","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.21037\/tcr-23-2032","article-title":"Mechanisms and characteristics of subcapsular sinus macrophages in tumor immunity: a narrative review","volume":"12","author":"Su","year":"2023","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.imlet.2025.107108_bib0059","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48916","article-title":"Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis","volume":"8","author":"Singh","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.imlet.2025.107108_bib0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/icb.2015.111","article-title":"The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles","volume":"94","author":"Black","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.imlet.2025.107108_bib0061","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1182\/bloodadvances.2021005327","article-title":"Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNF\u03b1","volume":"5","author":"Akhmetzyanova","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.imlet.2025.107108_bib0062","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1084\/jem.20182124","article-title":"Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression","volume":"216","author":"Etzerodt","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2025.107108_bib0063","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/pai.13400","article-title":"SIGLEC1 (CD169) as a potential diagnostical screening marker for monogenic interferonopathies","volume":"32","author":"Orak","year":"2021","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0064","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.aaf1328","article-title":"SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions","volume":"352","author":"Pucci","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.imlet.2025.107108_bib0065","first-page":"8589","article-title":"Research progress on CD169-positive macrophages in tumors","volume":"13","author":"Hou","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.imlet.2025.107108_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.672123","article-title":"Gene expression profiling of lymph node sub-capsular sinus macrophages in cancer","volume":"12","author":"Pellin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108993","article-title":"CD169+ lymph node macrophages have protective functions in mouse breast cancer metastasis","volume":"35","author":"Tacconi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.imlet.2025.107108_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1180209","article-title":"Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells","volume":"14","author":"Gunnarsdottir","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105271","article-title":"Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169+ macrophages by metastatic breast cancers","volume":"107","author":"Maeshima","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.imlet.2025.107108_bib0070","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/cas.12212","article-title":"CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma","volume":"104","author":"Ohnishi","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.imlet.2025.107108_bib0071","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/cas.13565","article-title":"CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis","volume":"109","author":"Asano","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.imlet.2025.107108_bib0072","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/cas.12929","article-title":"Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma","volume":"107","author":"Ohnishi","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.imlet.2025.107108_bib0073","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.4720","article-title":"CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma","volume":"239","author":"Zhang","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.imlet.2025.107108_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1466767","article-title":"Single-cell transcriptome analysis identifies a novel tumor-associated macrophage subtype predicting better prognosis in pancreatic ductal adenocarcinoma","volume":"12","author":"Wang","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.imlet.2025.107108_bib0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2025.02.027","article-title":"Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors","volume":"58","author":"Mauvais","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107108_bib0076","doi-asserted-by":"crossref","first-page":"e1305","DOI":"10.1002\/cti2.1305","article-title":"Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T-cell protective responses to breast cancer","volume":"10","author":"Mattiuz","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0077","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cell.2015.08.004","article-title":"Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions","volume":"162","author":"Eickhoff","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2025.107108_bib0078","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2025.107108_bib0079","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-024-01133-1","article-title":"CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors","author":"Lei","year":"2024","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.imlet.2025.107108_bib0080","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.124.071772","article-title":"Splenic cd169+tim4+ marginal metallophilic macrophages are essential for wound healing after myocardial infarction","volume":"151","author":"Ismahil","year":"2025","journal-title":"Circulation"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:53:01Z","timestamp":1781023981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":80,"alternative-id":["S0165247825001415"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107108","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Siglec-1+ macrophages in anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"107108"}}